Scopa James Paul has filed 19 insider transactions across 2 companies since July 2023.
Most recent transaction: a transaction of 10333 shares of Adverum Biotechnologies, Inc. ($ADVM) on December 09, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Scopa James Paul | Not found | U | Common Stock | 10333 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.04% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Scopa James Paul | Not found | D | Stock Option (Right to Buy) | 10450 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.04% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Scopa James Paul | Not found | D | Stock Option (Right to Buy) | 10520 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.04% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Scopa James Paul | Not found | D | Stock Option (Right to Buy) | 4000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.02% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Scopa James Paul | Not found | D | Stock Option (Right to Buy) | 4000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.02% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Scopa James Paul | Not found | D | Stock Option (Right to Buy) | 4000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.02% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Scopa James Paul | Not found | D | Stock Option (Right to Buy) | 3000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.01% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Scopa James Paul | Not found | D | Stock Option (Right to Buy) | 4500 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.02% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Scopa James Paul | Not found | D | Stock Option (Right to Buy) | 4666 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.02% |
| June 25, 2025 | Aligos Therapeutics, Inc. | $ALGS | Scopa James Paul | Not found | A | Stock Option (Right to Buy) | 5860 | $0.00 | 5,860.0000 | 3,864,436 | 9999.99% | 0.15% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Scopa James Paul | Not found | A | Stock Option (Right to Buy) | 10450 | $0.00 | 10,450.0000 | 19,782,000 | 9999.99% | 0.05% |
| June 27, 2024 | Aligos Therapeutics, Inc. | $ALGS | Scopa James Paul | Not found | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 3,003,855 | 9999.99% | 2.00% |
| June 17, 2024 | Adverum Biotechnologies, Inc. | $ADVM | Scopa James Paul | Not found | A | Stock Option (Right to Buy) | 10520 | $0.00 | 10,520.0000 | 16,479,000 | 9999.99% | 0.06% |
| Feb. 28, 2024 | Aligos Therapeutics, Inc. | $ALGS | Scopa James Paul | Not found | A | Stock Option (Right to Buy) | 8823 | $0.00 | 8,823.0000 | 3,003,855 | 9999.99% | 0.29% |
| Feb. 27, 2024 | Aligos Therapeutics, Inc. | $ALGS | Scopa James Paul | Not found | D | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 1.00% |
| Feb. 7, 2024 | Adverum Biotechnologies, Inc. | $ADVM | Scopa James Paul | Not found | P | Common Stock | 100000 | $1.35 | 103,334.0000 | 10,082,000 | 2999.40% | 0.99% |
| Oct. 25, 2023 | Aligos Therapeutics, Inc. | $ALGS | Scopa James Paul | Not found | A | Common Stock | 183083 | $0.76 | 183,083.0000 | 0 | 9999.99% | 0.00% |
| Oct. 25, 2023 | Aligos Therapeutics, Inc. | $ALGS | Scopa James Paul | Not found | A | Warrant (Right to Buy) | 91541 | $0.13 | 91,541.0000 | 0 | 9999.99% | 0.00% |
| July 20, 2023 | Aligos Therapeutics, Inc. | $ALGS | Scopa James Paul | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |